Literature DB >> 21807615

Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex.

Hiroki Yoshino1, Takeaki Miyamae, Gwenn Hansen, Brian Zambrowicz, Michael Flynn, Donna Pedicord, Yuval Blat, Ryan S Westphal, Robert Zaczek, David A Lewis, Guillermo Gonzalez-Burgos.   

Abstract

Depolarization-induced suppression of inhibition (DSI) is a prevailing form of endocannabinoid signalling. However, several discrepancies have arisen regarding the roles played by the two major brain endocannabinoids, 2-arachidonoylglycerol (2-AG) and anandamide, in mediating DSI. Here we studied endocannabinoid signalling in the prefrontal cortex (PFC), where several components of the endocannabinoid system have been identified, but endocannabinoid signalling remains largely unexplored. In voltage clamp recordings from mouse PFC pyramidal neurons, depolarizing steps significantly suppressed IPSCs induced by application of the cholinergic agonist carbachol. DSI in PFC neurons was abolished by extra- or intracellular application of tetrahydrolipstatin (THL), an inhibitor of the 2-AG synthesis enzyme diacylglycerol lipase (DAGL). Moreover, DSI was enhanced by inhibiting 2-AG degradation, but was unaffected by inhibiting anandamide degradation. THL, however, may affect other enzymes of lipid metabolism and does not selectively target the α (DAGLα) or β (DAGLβ) isoforms of DAGL. Therefore, we studied DSI in the PFC of DAGLα(-/-) and DAGLβ(-/-) mice generated via insertional mutagenesis by gene-trapping with retroviral vectors. Gene trapping strongly reduced DAGLα or DAGLβ mRNA levels in a locus-specific manner. In DAGLα(-/-) mice cortical levels of 2-AG were significantly decreased and DSI was completely abolished, whereas DAGLβ deficiency did not alter cortical 2-AG levels or DSI. Importantly, cortical levels of anandamide were not significantly affected in DAGLα(-/-) or DAGLβ(-/-) mice. The chronic decrease of 2-AG levels in DAGLα(-/-) mice did not globally alter inhibitory transmission or the response of cannabinoid-sensitive synapses to cannabinoid receptor stimulation, although it altered some intrinsic membrane properties. Finally, we found that repetitive action potential firing of PFC pyramidal neurons suppressed synaptic inhibition in a DAGLα-dependent manner. These results show that DSI is a prominent form of endocannabinoid signalling in PFC circuits. Moreover, the close agreement between our pharmacological and genetic studies indicates that 2-AG synthesized by postsynaptic DAGLα mediates DSI in PFC neurons.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21807615      PMCID: PMC3224880          DOI: 10.1113/jphysiol.2011.212225

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  102 in total

1.  Molecular composition of the endocannabinoid system at glutamatergic synapses.

Authors:  István Katona; Gabriella M Urbán; Matthew Wallace; Catherine Ledent; Kwang-Mook Jung; Daniele Piomelli; Ken Mackie; Tamás F Freund
Journal:  J Neurosci       Date:  2006-05-24       Impact factor: 6.167

Review 2.  Endocannabinoid-mediated control of synaptic transmission.

Authors:  Masanobu Kano; Takako Ohno-Shosaku; Yuki Hashimotodani; Motokazu Uchigashima; Masahiko Watanabe
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

Review 3.  Cellular basis of working memory.

Authors:  P S Goldman-Rakic
Journal:  Neuron       Date:  1995-03       Impact factor: 17.173

4.  Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex.

Authors:  S M Eggan; D S Melchitzky; S R Sesack; K N Fish; D A Lewis
Journal:  Neuroscience       Date:  2010-06-11       Impact factor: 3.590

5.  N- and L-type calcium channel involvement in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells.

Authors:  R A Lenz; J J Wagner; B E Alger
Journal:  J Physiol       Date:  1998-10-01       Impact factor: 5.182

6.  Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells.

Authors:  T A Pitler; B E Alger
Journal:  J Neurosci       Date:  1992-10       Impact factor: 6.167

7.  Selective, state-dependent activation of somatostatin-expressing inhibitory interneurons in mouse neocortex.

Authors:  Erika E Fanselow; Kristen A Richardson; Barry W Connors
Journal:  J Neurophysiol       Date:  2008-09-17       Impact factor: 2.714

8.  Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons.

Authors:  Dale A Fortin; Eric S Levine
Journal:  Cereb Cortex       Date:  2006-02-08       Impact factor: 5.357

9.  Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention.

Authors:  Brian P Zambrowicz; Alejandro Abuin; Ramiro Ramirez-Solis; Lizabeth J Richter; James Piggott; Hector BeltrandelRio; Eric C Buxton; Joel Edwards; Rick A Finch; Carl J Friddle; Anupma Gupta; Gwenn Hansen; Yi Hu; Wenhu Huang; Crystal Jaing; Billie Wayne Key; Peter Kipp; Buckley Kohlhauff; Zhi-Qing Ma; Diane Markesich; Robert Payne; David G Potter; Ny Qian; Joseph Shaw; Jeff Schrick; Zheng-Zheng Shi; Mary Jean Sparks; Isaac Van Sligtenhorst; Peter Vogel; Wade Walke; Nianhua Xu; Qichao Zhu; Christophe Person; Arthur T Sands
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

10.  Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex.

Authors:  Mathieu Lafourcade; Izaskun Elezgarai; Susana Mato; Yamina Bakiri; Pedro Grandes; Olivier J Manzoni
Journal:  PLoS One       Date:  2007-08-08       Impact factor: 3.240

View more
  53 in total

1.  Key questions of endocannabinoid signalling in the CNS: which, where and when?

Authors:  Charles J Frazier
Journal:  J Physiol       Date:  2011-10-15       Impact factor: 5.182

Review 2.  Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know.

Authors:  Bradley E Alger
Journal:  J Physiol       Date:  2012-01-30       Impact factor: 5.182

3.  Preformed vs. on-demand: molecular economics of endocannabinoid signalling.

Authors:  Charles J Frazier
Journal:  J Physiol       Date:  2013-10-01       Impact factor: 5.182

Review 4.  Functional Relevance of Endocannabinoid-Dependent Synaptic Plasticity in the Central Nervous System.

Authors:  Shana M Augustin; David M Lovinger
Journal:  ACS Chem Neurosci       Date:  2018-02-19       Impact factor: 4.418

5.  Diacylglycerol lipase β inhibition reverses nociceptive behaviour in mouse models of inflammatory and neuropathic pain.

Authors:  J L Wilkerson; S Ghosh; D Bagdas; B L Mason; M S Crowe; K L Hsu; L E Wise; S G Kinsey; M I Damaj; B F Cravatt; A H Lichtman
Journal:  Br J Pharmacol       Date:  2016-04-08       Impact factor: 8.739

6.  Cyclic AMP-dependent protein kinase and D1 dopamine receptors regulate diacylglycerol lipase-α and synaptic 2-arachidonoyl glycerol signaling.

Authors:  Brian C Shonesy; Jason R Stephenson; Christian R Marks; Roger J Colbran
Journal:  J Neurochem       Date:  2020-03-05       Impact factor: 5.372

Review 7.  Monoacylglycerol lipase - a target for drug development?

Authors:  C J Fowler
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

8.  2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.

Authors:  Alvaro Llorente-Berzal; Ana Luisa B Terzian; Vincenzo di Marzo; Vincenzo Micale; Maria Paz Viveros; Carsten T Wotjak
Journal:  Psychopharmacology (Berl)       Date:  2015-03-28       Impact factor: 4.530

9.  The initiation of synaptic 2-AG mobilization requires both an increased supply of diacylglycerol precursor and increased postsynaptic calcium.

Authors:  Brian C Shonesy; Danny G Winder; Sachin Patel; Roger J Colbran
Journal:  Neuropharmacology       Date:  2014-12-04       Impact factor: 5.250

Review 10.  Endogenous cannabinoid signaling at inhibitory interneurons.

Authors:  Thomas J Younts; Pablo E Castillo
Journal:  Curr Opin Neurobiol       Date:  2013-12-28       Impact factor: 6.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.